Aminoglycoside‐induced Translational Read‐through in Disease: Overcoming Nonsense Mutations by Pharmacogenetic Therapy

Overview of attention for article published in Clinical Pharmacology & Therapeutics, December 2006

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (88th percentile)
High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

patent: 5 patents

guideline: 1 clinical guideline source

Readers on

mendeley: 90 Mendeley

So far, Altmetric has seen 5 patents that reference this research output.

Inhibition of autism spectrum disorder using ribosomal read-through compounds

Grant US-11213537-B2

United States of America

04 Jan 2022

Methods of inducing read-through of a nonsense mutation associated with ataxia…

Grant US-10987370-B2

United States of America

27 Apr 2021

Read-through compound prodrugs suppressing premature nonsense mutations

Grant US-10287283-B2

United States of America

14 May 2019

INHIBITION OF AUTISM SPECTRUM DISORDER USING RIBOSOMAL READ-THROUGH COMPOUNDS

Application WO-2019053667-A1

World Intellectual Property Organisation (WIPO)

21 Mar 2019

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 1 additional patents.